Lv2
160 积分 2025-09-21 加入
Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML
13天前
已完结
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
20天前
已完结
Sonrotoclax: First Approval
1个月前
已完结
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
1个月前
已完结
BCL-2 and BTK inhibitors for chronic lymphocytic leukemia: current treatments and overcoming resistance
4个月前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
5个月前
已完结
Venetoclax in the treatment of chronic lymphocytic leukemia
5个月前
已完结
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia
5个月前
已关闭
Current Treatment Options in Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: a Review
5个月前
已完结
Venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: 6-year results of the randomized phase 3 CLL14 study
7个月前
已完结
皖公网安备34019202002308
